Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Lanxess Invests In Succinic Acid Maker
by Melody M. Bomgardner
February 27, 2012
| A version of this story appeared in
Volume 90, Issue 9
Biobased succinic acid producer BioAmber has raised $30 million in a third round of venture funding. Current investors including Naxos Capital and Mitsui & Co. contributed $20 million. Specialty chemical firm Lanxess invested $10 million and will receive a seat on BioAmber’s board. Lanxess owns a site in Ontario that will house BioAmber’s first commercial-scale succinic acid plant. In addition, the firms are working to develop plasticizers based on succinic acid. Last November, BioAmber filed for an initial public offering of stock worth up to $150 million.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X